- Home
- /
- News
- /
- Pharmacology/ Therapeutics
- /
- June 2014
Pharmacology/ Therapeutics News for June 2014
Dr Neil Murray, the CEO of Liverpool-headquartered biotech Redx Pharma, will join global health experts to discuss solutions to the threat of antimicrobial resistance (AMR) at the industry-leading BIO 2014 conference in San Diego this week.
27 June, 2014
New research funded by charity Action on Hearing Loss suggests that tinnitus can be eliminated by blocking signals between the ear and brain, offering hope to suffers that a cure is within reach, with prolonged exposure to loud music or working in a noisy environment often the main reasons why people are affected by the distressing condition.
16 June, 2014
Leading independent specialists with an interest in vitamin D today call on NICE to make clear the importance of regulated vitamin D products licensed by the MHRA (ie either prescription only medicines (POMs), pharmacy medicines (P) or general sales list (GSL) in its forthcoming public health guideline ‘Vitamin D: implementation of existing guidance to prevent deficiency’.
13 June, 2014
Haemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists have never understood why only some virus-infected people come down with the disease and others do not.
12 June, 2014
Experts from all over the world will convene this month to focus on ‘emerging and experimental therapies’ in the field of movement disorders.Parkinson’s disease is a key feature, and highlighted as being of growing importance in the field of movement disorders
11 June, 2014